MARKET

TWST

TWST

Twist Bioscience
NASDAQ

Real-time Quotes | Nasdaq Last Sale

40.00
+2.05
+5.40%
Closed 16:00 06/01 EDT
OPEN
38.12
PREV CLOSE
37.95
HIGH
40.15
LOW
37.22
VOLUME
653.34K
TURNOVER
--
52 WEEK HIGH
42.17
52 WEEK LOW
18.52
MARKET CAP
1.52B
P/E (TTM)
-9.0422
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TWST stock price target is 41.50 with a high estimate of 44.00 and a low estimate of 39.00.

EPS

TWST News

More
Twist Bioscience to Join Proteona in Global Alliance to Protect Immunocompromised Patients From COVID-19 Infection
Business Wire · 21h ago
Twist Bioscience to Present at the Jefferies Virtual Healthcare Conference
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present
Business Wire · 6d ago
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday's morning trading, 59 companies set new 52-week highs.
Benzinga · 05/19 14:43
The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18)
Benzinga · 05/19 12:27
Stocks That Hit 52-Week Highs On Monday
During the morning session on Monday, 120 stocks hit new 52-week highs.
Benzinga · 05/18 14:44
Schrodinger Shares Have More Than Tripled Since IPO
GuruFocus.com · 05/17 21:15
Twist Bioscience to Participate in the UBS Virtual Global Healthcare Conference
Business Wire · 05/12 13:00
Twist Bioscience Corporation (TWST) CEO Emily Leproust on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/10 15:58

Industry

Pharmaceuticals
-1.07%
Pharmaceuticals & Medical Research
-0.77%

Hot Stocks

Symbol
Price
%Change

About TWST

Twist Bioscience Corporation is a synthetic biology company. The Company is developing a disruptive deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company has a semiconductor-based synthetic DNA manufacturing process featuring 10,000-well silicon platform, which is capable of producing synthetic biology tools, such as genes, oligonucleotide pools and variant libraries. Its silicon-based DNA writing platform offers synthesis of genes on silicon. Its products include clonal perfect genes and non-clonal fragments. It offers protein scanning single variant libraries. Its design methodology, coupled with its silicon-based synthesis platform, enables synthesis of each library variant positioned exactly where user wants it to be. It offers unamplified oligo pools and cloning-ready oligo pools. Its platform offers synthesis of oligonucleotide pools for specific targeting.
More

Webull offers kinds of Twist Bioscience Corp stock information, including NASDAQ:TWST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TWST stock news, and many more online research tools to help you make informed decisions.